Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations

J Uy, L Fogelfeld, Y GuerraDivision of Endocrinology, Diabetes and Metabolism, John H Stroger Jr Hospital of Cook County, Chicago; Department of Endocrinology, Diabetes and Metabolism, Rush University Hospital, Chicago, IL, USAAbstract: We have now at our disposal the new rapid-acting insulin analog...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Uy J, Fogelfeld L, Guerra Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/28a2a29c6aa54edda42f5cf654835b30
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:28a2a29c6aa54edda42f5cf654835b30
record_format dspace
spelling oai:doaj.org-article:28a2a29c6aa54edda42f5cf654835b302021-12-02T00:02:10ZCumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations1178-7007https://doaj.org/article/28a2a29c6aa54edda42f5cf654835b302012-01-01T00:00:00Zhttp://www.dovepress.com/cumulative-clinical-experience-with-use-of-insulin-lispro-critical-app-a9025https://doaj.org/toc/1178-7007J Uy, L Fogelfeld, Y GuerraDivision of Endocrinology, Diabetes and Metabolism, John H Stroger Jr Hospital of Cook County, Chicago; Department of Endocrinology, Diabetes and Metabolism, Rush University Hospital, Chicago, IL, USAAbstract: We have now at our disposal the new rapid-acting insulin analogs, of which insulin lispro was the first to become commercially available. While the differences in pharmacokinetic and pharmacodynamic characteristics are indisputable, the clinical benefits attained by these changes have not been as clear. In the present review, we discuss the structure, pharmacology, and landmark studies related to insulin lispro. The clinical characteristics of insulin lispro are compared with those of insulin regular and other insulin analogs in different clinical situations. Also included are the aspects of quality of life and cost-effectiveness that may modify the modern practitioner's decision to adopt one type of insulin over another.Keywords: insulin lispro, rapid-acting, insulin, analogUy JFogelfeld LGuerra YDove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2012, Iss default, Pp 1-10 (2012)
institution DOAJ
collection DOAJ
language EN
topic Specialties of internal medicine
RC581-951
spellingShingle Specialties of internal medicine
RC581-951
Uy J
Fogelfeld L
Guerra Y
Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
description J Uy, L Fogelfeld, Y GuerraDivision of Endocrinology, Diabetes and Metabolism, John H Stroger Jr Hospital of Cook County, Chicago; Department of Endocrinology, Diabetes and Metabolism, Rush University Hospital, Chicago, IL, USAAbstract: We have now at our disposal the new rapid-acting insulin analogs, of which insulin lispro was the first to become commercially available. While the differences in pharmacokinetic and pharmacodynamic characteristics are indisputable, the clinical benefits attained by these changes have not been as clear. In the present review, we discuss the structure, pharmacology, and landmark studies related to insulin lispro. The clinical characteristics of insulin lispro are compared with those of insulin regular and other insulin analogs in different clinical situations. Also included are the aspects of quality of life and cost-effectiveness that may modify the modern practitioner's decision to adopt one type of insulin over another.Keywords: insulin lispro, rapid-acting, insulin, analog
format article
author Uy J
Fogelfeld L
Guerra Y
author_facet Uy J
Fogelfeld L
Guerra Y
author_sort Uy J
title Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
title_short Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
title_full Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
title_fullStr Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
title_full_unstemmed Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
title_sort cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/28a2a29c6aa54edda42f5cf654835b30
work_keys_str_mv AT uyj cumulativeclinicalexperiencewithuseofinsulinlisprocriticalappraisalroleintherapyandpatientconsiderations
AT fogelfeldl cumulativeclinicalexperiencewithuseofinsulinlisprocriticalappraisalroleintherapyandpatientconsiderations
AT guerray cumulativeclinicalexperiencewithuseofinsulinlisprocriticalappraisalroleintherapyandpatientconsiderations
_version_ 1718403972496097280